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= Abstract =
Since the first liver resection was carried out in Korea in 1959, there have been remarkable changes in the field 
of surgery. With technical advancement and the improvement of perioperative care, liver resections are widely per-
formed and surgical mortality is approaching zero. In the early 1990s, liver transplantation evolved as a feasible 
option in the treatment of end-stage liver disease in Korea, with successful adult living-donor liver transplantation 
(LDLT) as one of the greatest achievements. Various innovations in surgical approaches have been introduced. We 
review the current status of hepatic surgery in liver disease in Korea. 
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Abbreviations: LC, liver cirrhosis; HBV, hepatitis B; HCV, hepatitis C; PBC, primary biliary cirrhosis; AIH, auto-
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ing-donor liver transplantation; CDLT, cadaveric whole liver transplantation; DDLT, deceased-donor liver transplant; 
ACLF, acute on chronic liver failure; SBC, secondary biliary cirrhosis; PCLD, polycystic liver disease; BD, bile 
duct
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Figure 1. The change in post-
operative mortality rate after 
liver resection in Korea
The first liver resection was carried out in Korea in 1959. A right hepatectomy was performed on a 
52-year-old woman who had cholangiocarcinoma, but she died of bile peritonitis on the 9th postoperative day.1
Following that first liver resection, various procedures were carried out during the 1960s and 1970s for both 
malignant and benign conditions. According to reports on 189 cases and the number of liver resections per-
formed in several major hospitals from 1959~1978,2 the operations were not frequently performed during that 
period, and, unfortunately, nationwide statistical data was not collected. Perioperative mortality was 45.5% 
1959~1966, and 16% 1972~1978. 
From 1980 to 1990, liver resection was more widely practiced and mortality decreased (7.6%, 1977~1985).3 
During this period, many surgeons gradually began to consider residual liver function as an important prognostic 
factor. Various examinations for the evaluation of liver residual functions – ICG (indocyanine green) R15, ICG 
Rmax, oral GTT (oral glucose tolerance test), RTI (redox tolerance index) and AKBR (ketone body ratio) - 
were introduced, but there was no gold standard for estimating liver function. Combining several methods was 
inevitable, and the Child-Pugh score and ICG tests became the most popular in Korea. In the mid-1980s, the 
Cavitron Ultrasonic Surgical Aspirator for liver parenchymal dissection was introduced.4 
During the period 1990~2000, preoperative portal vein embolization in preparation for massive liver resection 
was introduced.5,6 Liver resection for various benign conditions like benign tumors and intrahepatic bile duct 
stone diseases were also the main issues in the field of liver surgery. During this same period, liver trans-
plantation caused an upsurge in the number of studies on donor hepatectomy.7 Liver resection is still considered 
the gold standard method of treatment for hepatocellular carcinoma (HCC), although some local ablative thera-
pies show good outcomes as well that are comparable to results after surgery. Since 1990, the outcomes of 
liver resection have improved. Perioperative mortality and morbidity has markedly decreased (morbidity 10%, 
mortality 1~2%)(Fig. 1).8,9
Surgery for variceal bleeding has undergone remarkable changes. Originally, various shunt operations were 
used for variceal bleeding, which is a major complication of portal hypertension. In the 1960s, most surgeons 
knew of the benefits of the selective shunt, especially the distal splenorenal shunt (Warren shunt).10 In the 
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Figure 2. Trends in liver transplantations in Korea. LDLT, living-donor liver transplant; DDLT, 
deceased-donor liver transplant (Excerpted from ‘Lee SG. Current status of liver transplantation in 
Korea. Korean J Gastroenterol 2005;46:75-83.’).
1970s, several variceal ablative procedures such as the Sugiura operation and the terminal esophago-proximal 
gastrectomy were introduced, but shunt operations were still the mainstay. In 1980, variceal ablative procedures 
were used in the majority of cases (91.6%). The Sugiura operation was one of the most popular procedures, 
but several variations including the Kobayashi operation and the Hassab operation were frequently used as 
well.11 Contrary to the trend in the West, non-shunt operations were preferred in Korea as they were in other 
Asian countries. As endoscopic procedures such as endoscopic injection sclerotherapy, endoscopic band ligation, 
and interventional methods like transjugular intrahepatic portosystemic shunt (TIPS) were developed, the use of 
surgical procedures for portal hypertension decreased.12-13
In Korea, the first liver transplantation was carried out in 1988 on a 13-year old Wilson's disease patient 
using the orthotopic whole organ cadaveric donor liver transplantation (CDLT) method.14 In 1994, a living donor 
liver transplantation (LDLT) was carried out on a 6-month-old patient with biliary atresia for the first time in 
Korea.7 The first Korean LDLT on an adult was performed in 1997.7 Since 1997, the number of liver trans-
plantations in Korea has grown remarkably on an annual basis. From 1988 to 2004, 2,345 liver transplantations 
(LDLT in 1,860 cases: 79.3%, CDLT in 485 cases: 20.7%) were carried out in Korea (Fig. 2).15 
As transplantations grew in number, many new challenges became evident, such as the reconstruction of the 
middle hepatic vein tributaries in right lobe LDLT to avoid anterior segment congestion, dual two-left-lobe graft 
LDLT to overcome graft-size insufficiency, and donor risk.7 In terms of prognosis after liver transplantation, 
in 1998, the 1-year graft survival rate after LDLT and CDLT in Korea was 80% and 62% respectively, but 
in 2004, it improved to 83% and 76% respectively.15 According to a report from 4 transplantation centers in 
Korea on liver transplantation for HCC, the perioperative mortality rate after liver transplantation on HCC pa-
tients was 18.7% for the CDLT group and 10.1% for the LDLT group, and the 3-year survival rate was 61.1% 
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Figure 3. The number of patients waiting for liver transplantation, in comparison with the number of living 
related and cadaveric donor liver transplantations performed.
Figure 4. The graph of 1,000 adults (age >18 
years) with living donor liver transplantations per-
formed between February 1997 and January 2006 
(Excerpted from ‘Lee SG. Towards 300 liver trans-
plants a year. Surg Today 2009;39:367-373’).
LC, liver cirrhosis; HBV, hepatitis B; HCV, hep-
atitis C; PBC, primary biliary cirrhosis; AIH, auto-
immune hepatitis; HCC, hepatocellular carcinoma; 
CCC, cholangiocarcinoma; ACLF, acute on chronic 
liver failure; SBC, secondary biliary cirrhosis; 
PCLD, polycystic liver disease.
for the CDLT group and 73.2% for the LDLT group.16 In 2007, in-hospital mortality fell to 5%, and since then, 
the liver transplantation donor mortality has not been reported.7 
The shortage of donors is a serious problem in Korea (Fig. 3). The law for organ transplantation and brain 
death was framed in Korea in 1999, and the Korean Network for Organ Sharing (KONOS) was organized. 
Despite these improvements, the annually reported brain death rate is 3.15 cases per 1,000,000 people, which 
is a very small number compared to the 10~33 cases reported in the West.17 Split liver transplantation provides 
an ideal means to expand the donor pool for both children and adults.7,18 Because of the limited number of 
donors, LDLT has inevitably been promoted. Indications for liver transplantation in Korea include liver cirrhosis 
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(LC) caused by the Hepatitis B virus (HBV), which is the most common, followed by HCC, acute fulminant 
hepatitis, and LC induced by alcohol (Fig. 4).7 
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